Your browser doesn't support javascript.
loading
Endocrinopathies induced by immune checkpoint inhibitors: the need for clear endocrine diagnosis.
Percik, Ruth; Larkin, James; Morganstein, Daniel L.
Affiliation
  • Percik R; Department of Endocrinology, Diabetes and Metabolism, Sheba Medical Centre, Israel.
  • Larkin J; Skin Unit, Royal Marsden Hospital, London, UK.
  • Morganstein DL; Skin Unit, Royal Marsden Hospital, London, UK; Department of Endocrinology, Chelsea and Westminster Hospital, London SW10 9NH, UK. Electronic address: d.morganstein@ic.ac.uk.
Lancet Oncol ; 22(7): 905-907, 2021 07.
Article in En | MEDLINE | ID: mdl-34197741
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endocrine System Diseases / Immune Checkpoint Inhibitors / Terminology as Topic Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endocrine System Diseases / Immune Checkpoint Inhibitors / Terminology as Topic Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication: